JP2019501687A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501687A5
JP2019501687A5 JP2018525783A JP2018525783A JP2019501687A5 JP 2019501687 A5 JP2019501687 A5 JP 2019501687A5 JP 2018525783 A JP2018525783 A JP 2018525783A JP 2018525783 A JP2018525783 A JP 2018525783A JP 2019501687 A5 JP2019501687 A5 JP 2019501687A5
Authority
JP
Japan
Prior art keywords
syringe
prefilled syringe
prefilled
vegf
silicone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018525783A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019501687A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/078136 external-priority patent/WO2017085253A1/en
Publication of JP2019501687A publication Critical patent/JP2019501687A/ja
Publication of JP2019501687A5 publication Critical patent/JP2019501687A5/ja
Priority to JP2022144630A priority Critical patent/JP2022177129A/ja
Pending legal-status Critical Current

Links

JP2018525783A 2015-11-18 2016-11-18 Ｖｅｇｆ拮抗薬を収容したプレフィルドプラスチックシリンジ Pending JP2019501687A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022144630A JP2022177129A (ja) 2015-11-18 2022-09-12 Ｖｅｇｆ拮抗薬を収容したプレフィルドプラスチックシリンジ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15195177.9 2015-11-18
EP15195177 2015-11-18
PCT/EP2016/078136 WO2017085253A1 (en) 2015-11-18 2016-11-18 Pre-filled plastic syringe containing a vegf antagonist

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022144630A Division JP2022177129A (ja) 2015-11-18 2022-09-12 Ｖｅｇｆ拮抗薬を収容したプレフィルドプラスチックシリンジ

Publications (2)

Publication Number Publication Date
JP2019501687A JP2019501687A (ja) 2019-01-24
JP2019501687A5 true JP2019501687A5 (https=) 2020-01-09

Family

ID=54608352

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018525783A Pending JP2019501687A (ja) 2015-11-18 2016-11-18 Ｖｅｇｆ拮抗薬を収容したプレフィルドプラスチックシリンジ
JP2022144630A Pending JP2022177129A (ja) 2015-11-18 2022-09-12 Ｖｅｇｆ拮抗薬を収容したプレフィルドプラスチックシリンジ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022144630A Pending JP2022177129A (ja) 2015-11-18 2022-09-12 Ｖｅｇｆ拮抗薬を収容したプレフィルドプラスチックシリンジ

Country Status (11)

Country Link
US (3) US20180326126A1 (https=)
EP (1) EP3377151A1 (https=)
JP (2) JP2019501687A (https=)
KR (1) KR20180083377A (https=)
CN (1) CN108290004A (https=)
AU (1) AU2016356047B2 (https=)
BR (1) BR112018010005A2 (https=)
MX (1) MX2018006171A (https=)
RU (1) RU2018121813A (https=)
WO (1) WO2017085253A1 (https=)
ZA (1) ZA201802922B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
KR20250057128A (ko) 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
US10576128B2 (en) 2016-01-26 2020-03-03 Formycon Ag Liquid formulation of a VEGF antagonist
CN117138171A (zh) 2017-12-13 2023-12-01 里珍纳龙药品有限公司 用于精确剂量输送的装置和方法
US20200390596A1 (en) 2018-01-03 2020-12-17 Irenix Medical, Inc. Therapeutic Agent Delivery Devices Having Integrated Pain Mitigation, and Methods for Using the Same
AU2019212622B2 (en) 2018-01-26 2024-05-23 The Regents Of The University Of California Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents
EP3758737A4 (en) 2018-03-02 2022-10-12 Kodiak Sciences Inc. IL-6 ANTIBODIES AND FUSION CONSTRUCTS AND CONJUGATES THEREOF
DK4364724T3 (da) 2018-05-10 2025-12-22 Regeneron Pharma Formuleringer med høj koncentration af VEGF-receptorfusionsprotein
MY195550A (en) * 2018-10-29 2023-01-31 Hoffmann La Roche Antibody Formulation
EP3659594B2 (de) * 2018-11-30 2026-04-29 Klaus Stegemann Eine sterile lösung mit einem medizinischen wirkstoff enthaltende applikationsspritze und verfahren für deren bereitstellung
EP3886946A1 (en) 2019-06-05 2021-10-06 Regeneron Pharmaceuticals, Inc. Devices and methods for precision dose delivery
TWI904098B (zh) 2019-09-03 2025-11-11 美商安進公司 用於藥物遞送之注入裝置及用於注入裝置之包裝物
MX2022002980A (es) 2019-09-16 2022-04-06 Amgen Inc Metodo para la esterilizacion externa de un dispositivo de suministro de farmacos.
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
BR112022010113A2 (pt) 2019-11-25 2022-09-06 Univ California Inibidores de vegf de longa ação para neovascularização intraocular
SG11202110968VA (en) 2019-12-06 2021-10-28 Regeneron Pharma Anti-vegf protein compositions and methods for producing the same
AU2021268026A1 (en) 2020-05-08 2023-01-19 Regeneron Pharmaceuticals, Inc. VEGF traps and mini-traps and methods for treating ocular disorders and cancer
EP4196060A1 (en) * 2020-08-12 2023-06-21 Regeneron Pharmaceuticals, Inc. Systems and methods for drug delivery to ocular tissue
US20230226280A1 (en) * 2020-09-25 2023-07-20 Ocuject, Llc Syringe injector with a feedback mechanism
KR102720956B1 (ko) * 2020-12-15 2024-10-24 삼천당제약주식회사 안과용 제형을 포함하는 시린지
WO2022207655A1 (en) * 2021-03-30 2022-10-06 Schott Schweiz Ag System for low-temperature storage of a pharmaceutical composition, liquid composition, method and uses
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3380450A (en) * 1965-05-10 1968-04-30 William H. Adelberger Sterile disposable plastic prefilled syringe
US6124449A (en) 1990-06-11 2000-09-26 Nexstar Pharmaceuticals, Inc. High affinity TGFβ nucleic acid ligands and inhibitors
US5731144A (en) 1990-06-11 1998-03-24 Nexstar Pharmaceuticals, Inc. High affinity TGFβ nucleic acid ligands
US5731424A (en) 1990-06-11 1998-03-24 Nexstar Pharmaceuticals, Inc. High affinity TGFβ nucleic acid ligands and inhibitors
US6582959B2 (en) 1991-03-29 2003-06-24 Genentech, Inc. Antibodies to vascular endothelial cell growth factor
AU687727B2 (en) 1992-10-28 1998-03-05 Genentech Inc. Vascular endothelial cell growth factor antagonists
IL117645A (en) 1995-03-30 2005-08-31 Genentech Inc Vascular endothelial cell growth factor antagonists for use as medicaments in the treatment of age-related macular degeneration
JP4531132B2 (ja) 1995-06-02 2010-08-25 ギリード・サイエンシズ・インコーポレーテッド 増殖因子に対する高親和性オリゴヌクレオチドリガンド
PT971959E (pt) 1997-04-07 2006-05-31 Genentech Inc Anticorpos humanizados e metodos para formar anticorpos humanizados
KR100816621B1 (ko) 1997-04-07 2008-03-24 제넨테크, 인크. 항-ｖｅｇｆ 항체
US20020032315A1 (en) 1997-08-06 2002-03-14 Manuel Baca Anti-vegf antibodies
US6703020B1 (en) 1999-04-28 2004-03-09 Board Of Regents, The University Of Texas System Antibody conjugate methods for selectively inhibiting VEGF
CN101433715B (zh) 1999-06-08 2013-04-17 里珍纳龙药品有限公司 具有改善的药物动力学特性的修饰嵌合多肽
US7431989B2 (en) 2003-05-06 2008-10-07 Tribofilm Research, Inc. Article with lubricated surface and method
WO2005044853A2 (en) 2003-11-01 2005-05-19 Genentech, Inc. Anti-vegf antibodies
AU2009210741A1 (en) * 2008-02-07 2009-08-13 Amgen Inc. Stabilized protein compositions
BRPI0914251B1 (pt) 2008-06-25 2022-07-19 Novartis Ag Imunoligante recombinante, seu fragmento de ligação ao antígeno, uso dos mesmos, e composição
BRPI0921469B1 (pt) 2008-11-03 2022-01-18 Molecular Partners Ag Proteínas de ligação que inibem a interação com o receptor de vegf-a, composição farmacêutica
US9597458B2 (en) * 2009-10-29 2017-03-21 W. L. Gore & Associates, Inc. Fluoropolymer barrier materials for containers
WO2011117878A1 (en) 2010-03-20 2011-09-29 Pawan Trilokchand Agrawal Plastic pre-filled syringe
CN106137528B (zh) * 2010-03-31 2020-12-01 奥库杰克特有限责任公司 用于眼内药物递送的设备和方法
AR081361A1 (es) 2010-04-30 2012-08-29 Molecular Partners Ag Proteinas de union modificadas que inhiben la interaccion de receptor del factor de crecimiento endotelial vascular de glicoproteina a vegf-a
DE102011009057B4 (de) * 2011-01-20 2015-12-10 Schott Ag Plasma-Behandlungsvorrichtung zur Herstellung von Beschichtungen und Verfahren zur innenseitigen Plasmabehandlung von Behältern
WO2013115331A1 (ja) * 2012-01-31 2013-08-08 テルモ株式会社 プレフィルドシリンジ用シリンジ
PL3777834T3 (pl) * 2012-06-01 2022-05-30 Novartis Ag Strzykawka
AU2012101677B4 (en) 2012-07-03 2012-12-20 Novartis Ag Device
DE202013000688U1 (de) * 2012-07-03 2013-03-05 Novartis Ag Glas-Spritze
EP2890389A1 (en) * 2012-08-28 2015-07-08 Novartis AG Use of a vegf antagonist in treating ocular vascular proliferative diseases
DE102013103676A1 (de) * 2013-04-11 2014-10-30 Schott Ag Behälter mit geringer Partikelemission und reibkontrollierter Trockengleitoberfläche, sowie Verfahren zu dessen Herstellung
EP3019526A1 (en) * 2013-07-11 2016-05-18 Novartis AG Use of a vegf antagonist in treating chorioretinal neovascular and permeability disorders in paediatric patients
EP3055003B1 (en) * 2013-10-07 2019-04-24 Ocuject, LLC Intraocular delivery devices
AU2015326037A1 (en) * 2014-10-02 2017-04-13 Terumo Kabushiki Kaisha Medical container for accommodating protein solution preparation therein

Similar Documents

Publication Publication Date Title
JP2019501687A5 (https=)
RU2018121813A (ru) Предварительно заполненный пластиковый шприц, содержащий антагонист vegf
RU2016148324A (ru) Предварительно заполненный пластиковый шприц, содержащий антагонист vegf
TWI632920B (zh) 注射器
JP6396565B2 (ja) 抗インターロイキン−４受容体（ｉｌ−４ｒ）抗体を含有する安定化製剤
DK2521536T3 (en) STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES
TW201726194A (zh) 用於移除帽蓋的系統（二）
JP2014087678A5 (https=)
JP7695887B2 (ja) 抗ｉｌ－３３抗体を含有する安定化製剤
JP2019510078A5 (https=)
KR102373289B1 (ko) 지속성 부종을 갖는 삼출성 노인성 황반변성을 치료하기 위한 시롤리무스의 용도
JP2024519629A5 (https=)
KR20230135012A (ko) 혈관형성 눈 장애의 치료를 위한 연장된 고 용량 vegf 길항제 용법
KR20220085906A (ko) 안과용 제형을 포함하는 시린지
TWI856388B (zh) 含有抗-介白素-4受體(il-4r)抗體之安定化配製物
EP3145532A1 (en) Individualized treatment of eye disease
Kim et al. Differences in the incidence of aflibercept-related sterile endophthalmitis according to types of disposable syringes used
EP3202393B1 (en) Intradermal administration of immunoglobulin g preparation
Hsia et al. Rescue effects of intravitreal aflibercept in the treatment of neovascular age-related macular degeneration
Forte et al. Retinal Vein Occlusion Following Two Doses of mRNA-1237 (Moderna) Immunization for SARS-Cov-2: A Case Report
HK40030912A (en) Syringe
Bosnar RANIBIZUMAB FOR NAMD: NEW EVIDENCE TO IMPROVE PATIENT CARE.
Cankaya Acinetobacter baumannii endophthalmitis following intravitreal administration in an elderly patient: case report
Awwad et al. In vitro evaluation of the therapeutic tail of bevacizumab in the eye